.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Asisa Volz

Hanover / DE

University of Veterinary Medicine Hannover

Vorsitz

04.03.2025
16:00 – 17:30
Workshop
Zoonoses and epidemic threads
Audimax I

Weitere Beteiligungen

04.03.2025
Poster
P 052
Synergistic interference with SARS-CoV-2 replication by Molnupiravir-derived N4 hydroxycytidine and inhibitors of CTP synthetase
Antiviral therapy and resistance
04.03.2025
Poster
P 250
Immunogenicity of licensed vaccines against West Nile Virus infections in horses
Veterinary virology
04.03.2025
Poster
P 280
Immunogenicity of Two Modified Vaccinia virus Ankara (MVA)-based Candidate Vaccines encoding Lassa Virus Glycoprotein or Nucleoprotein in mice
Viral vectors and vaccines
04.03.2025
Poster
P 305
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection
Viral vectors and vaccines
04.03.2025
Poster
P 307
Generation of a recMVA vaccine candidate targeting EVD68-VP1
Viral vectors and vaccines
04.03.2025
Poster
P 309
Improved Immunogenicity and Protective Capacity of Single Dose Vaccination with Stabilized Recombinant MERS-CoV Spike Antigen
Viral vectors and vaccines
04.03.2025
Poster
P 310
Rapid protective MVA-SARS-2-ST vaccination induces robust T cell responses against SARS-CoV-2 in Syrian hamsters
Viral vectors and vaccines
04.03.2025
16:15 – 16:30 12 Min. 3 Min.
Abstract talk
O 008
Strong and early activation of mpox virus-specific immunity associated with mild disease after intradermal clade IIb-infection in CAST/Eij-mice
Zoonoses and epidemic threads
04.03.2025
19:00 – 19:15 12 Min. 3 Min.
Abstract talk
O 022
Modified Vaccinia virus Ankara-based vaccine candidate provides cross-protection against lethal MARV challenge in a single-dose vaccination regimen
Viral vectors and vaccines
06.03.2025
09:30 – 09:45 12 Min. 3 Min.
Abstract talk
O 087
MVA-based therapeutic approaches against equine hepacivirus infections in horses
Veterinary virology
07.03.2025
11:45 – 12:00 12 Min. 3 Min.
Abstract talk
O 109
Spike proteins of MERS-CoV isolates from dromedary camels present in Africa and the Arabian Peninsula exhibit differential sensitivity to inhibition by soluble DPP4
Virus-host interactions